AUNDREA WALLACE: Open Payments
NPI 1053930404 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 34 payments from 15 companies in 2025. Trend: 2023 $127 · 2024 $0 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $84 |
| PFIZER INC. | 4 | $64 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| ABBVIE INC. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $45 |
| Dexcom, Inc. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 3 | $42 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
Products named: TRELEGY ELLIPTA, Rybelsus, UBRELVY, AIRSUPRA, PREVNAR 20, Kerendia, Dexcom G6 Transmitter, VOQUEZNA.
Industry payments across TN — which companies pay providers there.
